ANVISA registration 81816720089Valid until Mar 02, 2036

HERPES VIRUS (HHV 2)

Name: HERPES VIRUS (HHV 2) — ANVISA registration 81816720089
Creator: VIRCELL S.L.
Keywords: HERPES VIRUS (HHV 2), HERPES VÍRUS (HHV 2), HERPES SIMPLEX 1+2 VIRCLIA® IgG MONOTEST, 81816720089, Risk Class III, ANVISA registration

ANVISA Registration Number: 81816720089ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDAVIRCELL S.L.Risk Class III

Verified

Device names

Technical name: HERPES VIRUS (HHV 2)
Commercial name: HERPES SIMPLEX 1+2 VIRCLIA® IgG MONOTEST
Risk class: Class III

Registration details

Registration Number: 81816720089
Process Number: 25351151424202549
CNPJ: 31167508000102

Company information

Registration Holder: ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA
Manufacturer: VIRCELL S.L.
Manufacturing Country: Spain

Dates and status

Publication Date: Mar 02, 2026
Validity: 02/03/2036
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81816720089 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Mar 02, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.